These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 12203366

  • 21. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C, Chattopadhyay A, Parkhurst C, Yang E.
    Oncogene; 2002 Nov 07; 21(51):7765-75. PubMed ID: 12420213
    [Abstract] [Full Text] [Related]

  • 22. Down-regulation of the retinoblastoma protein (rb) is associated with rat oligodendrocyte differentiation.
    Huang Z, Tang XM, Cambi F.
    Mol Cell Neurosci; 2002 Feb 07; 19(2):250-62. PubMed ID: 11860277
    [Abstract] [Full Text] [Related]

  • 23. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.
    Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461
    [Abstract] [Full Text] [Related]

  • 24. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27.
    Park WH, Seol JG, Kim ES, Jung CW, Lee CC, Binderup L, Koeffler HP, Kim BK, Lee YY.
    Exp Cell Res; 2000 Feb 01; 254(2):279-86. PubMed ID: 10640426
    [Abstract] [Full Text] [Related]

  • 25. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
    Barnouin K, Fredersdorf S, Eddaoudi A, Mittnacht S, Pan LX, Du MQ, Lu X.
    Oncogene; 1999 Nov 04; 18(46):6388-97. PubMed ID: 10597239
    [Abstract] [Full Text] [Related]

  • 26. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR.
    Nature; 1997 May 22; 387(6631):422-6. PubMed ID: 9163430
    [Abstract] [Full Text] [Related]

  • 27. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.
    Suzuki A, Hayashida M, Ito T, Kawano H, Nakano T, Miura M, Akahane K, Shiraki K.
    Oncogene; 2000 Jul 06; 19(29):3225-34. PubMed ID: 10918579
    [Abstract] [Full Text] [Related]

  • 28. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M, Labriola L, Schillaci R, Charreau EH, Elizalde PV.
    Exp Cell Res; 2001 Apr 15; 265(1):152-66. PubMed ID: 11281653
    [Abstract] [Full Text] [Related]

  • 29. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
    Zhou J, Ma J, Zhang BC, Li XL, Shen SR, Zhu SG, Xiong W, Liu HY, Huang H, Zhou M, Li GY.
    J Cell Physiol; 2004 Jul 15; 200(1):89-98. PubMed ID: 15137061
    [Abstract] [Full Text] [Related]

  • 30. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS.
    Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
    Srethapakdi M, Liu F, Tavorath R, Rosen N.
    Cancer Res; 2000 Jul 15; 60(14):3940-6. PubMed ID: 10919672
    [Abstract] [Full Text] [Related]

  • 32. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
    Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y.
    J Cell Biochem; 1999 Sep 01; 74(3):486-98. PubMed ID: 10412049
    [Abstract] [Full Text] [Related]

  • 33. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
    Shapiro GI, Park JE, Edwards CD, Mao L, Merlo A, Sidransky D, Ewen ME, Rollins BJ.
    Cancer Res; 1995 Dec 15; 55(24):6200-9. PubMed ID: 8521414
    [Abstract] [Full Text] [Related]

  • 34. Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators.
    Yin F, Wakino S, Liu Z, Kim S, Hsueh WA, Collins AR, Van Herle AJ, Law RE.
    Biochem Biophys Res Commun; 2001 Sep 07; 286(5):916-22. PubMed ID: 11527386
    [Abstract] [Full Text] [Related]

  • 35. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
    Haddad MM, Xu W, Schwahn DJ, Liao F, Medrano EE.
    Exp Cell Res; 1999 Dec 15; 253(2):561-72. PubMed ID: 10585280
    [Abstract] [Full Text] [Related]

  • 36. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.
    J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912
    [Abstract] [Full Text] [Related]

  • 37. Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway.
    Ouyang XS, Wang X, Ling MT, Wong HL, Tsao SW, Wong YC.
    Carcinogenesis; 2002 May 15; 23(5):721-5. PubMed ID: 12016143
    [Abstract] [Full Text] [Related]

  • 38. Id-1 promotes proliferation of p53-deficient esophageal cancer cells.
    Hui CM, Cheung PY, Ling MT, Tsao SW, Wang X, Wong YC, Cheung AL.
    Int J Cancer; 2006 Aug 01; 119(3):508-14. PubMed ID: 16506209
    [Abstract] [Full Text] [Related]

  • 39. Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27.
    Zhang YW, Morita I, Ikeda M, Ma KW, Murota S.
    Oncogene; 2001 Jul 12; 20(31):4138-49. PubMed ID: 11464280
    [Abstract] [Full Text] [Related]

  • 40. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells.
    Lo AK, Huang DP, Lo KW, Chui YL, Li HM, Pang JC, Tsao SW.
    Int J Cancer; 2004 May 10; 109(6):919-25. PubMed ID: 15027126
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.